A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Clinical trial NCT06177925 · RECRUITING
Trial details
- NCT number
- NCT06177925
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-10
- Primary completion
- 2026-06-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.